Frontlight ResearchEarly access
CompletedNo phase
Visual Quality and Performance of Eyes With Asqelio™ EDoF Toric Lenses
Key facts
- Who runs it
- AST Products, Inc.
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 11 Jan 2023
- Ended
- 14 May 2024
- Type of study
- Observational, 2 groups
- Record updated
- 27 August 2025
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 28 criteriaShow less
Who can take part
- Patients aged 50 years or older who have undergone cataract surgery with phacoemulsification or refractive lensectomy, with bilateral implantation of the Asqelio EDOF toric IOL model ETLIO130C/ETPIO130C with a cylinder value of 0.0 D, or the spherical monofocal J\&J TECNIS 1-Piece IOL model ZCB00
- Patients who have signed the informed consent form
- Clear intraocular media, except for the presence of cataracts in both eyes prior to surgery
- Postoperative potential visual acuity of 20/25 or better
Who cannot take part
- Previous corneal surgery or trauma
- Severe concomitant ocular disease
- Previous retinal detachment
- Concurrent participation in another drug or clinical device investigation
- Expectation of needing another ocular surgery during the study period
- Choroidal hemorrhage
- Preoperative corneal astigmatism greater than 1.00D
- Patients who do not provide informed consent
- Patients who do not understand the study procedure
- Irregular cornea (e.g., keratoconus)
- Microphthalmos
- Severe corneal dystrophy
- Uncontrolled or medically controlled glaucoma
- Clinically significant macular changes
- Cataract unrelated to aging
- Severe optic nerve atrophy
- Diabetic retinopathy
- Proliferative diabetic retinopathy
- Amblyopia
- Extremely shallow anterior chamber
- Severe chronic uveitis
- Pregnant or breastfeeding
- Rubella
- Mature/dense cataract preventing preoperative fundus examination
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the optical quality and clinical performance of the Asqelio™ EDOF Toric intraocular lens (IOL) in patients undergoing cataract surgery or refractive lensectomy. The Asqelio™ EDOF Toric IOL aims to provide improved vision at various distances and correct astigmatism compared to monofocal IOLs. Postoperative outcomes, including visual clarity, refractive correction, and patient satisfaction, will be assessed three months after surgery.
The 2 groups in the trial
- Asqelio EDOF
Patients submitted to cataract surgery and implanted with the extended depth-of-focus intraocular lens Asqelio EDOF Toric
- Monofocal IOL
Patients submitted to cataract surgery and implanted with the TECNIS 1-Piece monofocal intraocular lens
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- In Situ Analysis of the Optical Quality and Visual Solvency of Eyes Implanted Bilaterally With the Asqelio™ EDoF Toric Extended-focus Intraocular Lens
- Record updated
- 27 August 2025